An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 021149
Company: EMD SERONO

This Former NDA Was Deemed To Be a BLA on March 23, 2020.

Products on BLA 021149

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
OVIDREL	CHORIOGONADOTROPIN ALFA	0.25MG/VIAL	INJECTABLE;INJECTION	Discontinued	None	No	No
OVIDREL	CHORIOGONADOTROPIN ALFA	EQ 0.25MG /0.5ML	INJECTABLE;SUBCUTANEOUS	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 021149

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/20/2000	ORIG-1	Approval		N/A	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21149lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21149ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-149_Ovidrel.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/30/2015	SUPPL-40	Supplement		Label is not available on this site.
12/11/2014	SUPPL-39	Supplement		Label is not available on this site.
12/19/2013	SUPPL-37	Supplement		Label is not available on this site.
12/11/2013	SUPPL-36	Supplement		Label is not available on this site.
04/11/2013	SUPPL-35	Supplement		Label is not available on this site.
04/05/2013	SUPPL-34	Supplement		Label is not available on this site.
01/31/2013	SUPPL-33	Supplement		Label is not available on this site.
02/08/2013	SUPPL-32	Supplement		Label is not available on this site.
01/15/2013	SUPPL-31	Supplement		Label is not available on this site.
01/31/2013	SUPPL-30	Supplement		Label is not available on this site.
01/15/2013	SUPPL-29	Supplement		Label is not available on this site.
12/10/2012	SUPPL-26	Supplement		Label is not available on this site.
12/13/2012	SUPPL-25	Supplement		Label is not available on this site.
06/02/2010	SUPPL-20	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021149s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021149s020ltr.pdf
07/09/2013	SUPPL-17	Supplement		Label is not available on this site.
07/30/2007	SUPPL-13	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021149s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021149s013ltr.pdf
07/14/2003	SUPPL-6	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21149slr006ltr.pdf
05/15/2002	SUPPL-1	Supplement		Label is not available on this site.

Labels for BLA 021149

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/02/2010	SUPPL-20	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021149s020lbl.pdf
07/30/2007	SUPPL-13	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021149s013lbl.pdf
09/20/2000	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21149lbl.pdf

Top